Compounds > n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide
Page last updated: 2024-09-05

n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Skin Neoplasms

n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide has been researched along with Skin Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aamdal, S; Awada, A; Baron, B; Caponigro, F; Dittrich, C; Djurasinovic, N; Fumoleau, P; Gore, M; Lesimple, T; Punt, CJ; Ravic, M; Schöffski, P; Smyth, JF1
Baur, M; Dittrich, C; Gneist, M; Owa, T1

Trials

1 trial(s) available for n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Skin Neoplasms

ArticleYear
Phase II study of E7070 in patients with metastatic melanoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:1

    Topics: Adult; Aged; Disease Progression; Female; Humans; Infusions, Intravenous; Male; Melanoma; Middle Aged; Skin Neoplasms; Sulfonamides; Treatment Outcome

2005

Other Studies

1 other study(ies) available for n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Skin Neoplasms

ArticleYear
Clinical complete long-term remission of a patient with metastatic malignant melanoma under therapy with indisulam (E7070).
    Melanoma research, 2007, Volume: 17, Issue:5

    Topics: Antineoplastic Agents; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Remission Induction; Skin Neoplasms; Sulfonamides

2007